Core Viewpoint - The company, Novozymes, is focused on providing core raw materials and reagents necessary for the production of semaglutide through synthetic biology fermentation methods, catering to various downstream clients [1] Group 1: Product Offerings - The GLP-1 product line includes high specificity and high-capacity raw enzymes and various specifications of intermediate peptides [1] - The company has developed comprehensive quality control testing kits to ensure product reliability [1] Group 2: Client Engagement - Novozymes has successfully supplied hundreds of kilograms of materials to multiple domestic clients [1] - The company offers customized process optimization solutions to enhance production efficiency for its clients [1] Group 3: Production Scope - Currently, the company does not engage in the production of related weight-loss medications [1]

Core Viewpoint - The company Novozymes (688105.SH) has announced its GLP-1 product line and solutions, which primarily provide essential raw materials and reagents needed for the biological fermentation production of Semaglutide for downstream customers [1] Group 1 - The product offerings include highly specific and high-capacity raw enzymes and various specifications of intermediate peptides, accompanied by comprehensive quality control testing kits [1] - The company has successfully supplied hundreds of kilograms to multiple domestic clients [1] - To meet diverse customer needs, the company offers customized process optimization solutions to help clients improve production efficiency [1] Group 2 - Currently, the company does not engage in the production of related weight-loss drugs [1]